Simplex Trading, LLC Viking Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

A detailed history of Simplex Trading, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 81,307 shares of VKTX stock, worth $4.4 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

81,307

Previous 57,999 40.19%

Holding current value

$4.4 Million

Previous $4.76 Million 9.36%

% of portfolio

0.14%

Previous 0.14%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$47.39 - $80.2 $1.1 Million - $1.87 Million	23,308 Added 40.19%	81,307 $4.31 Million
Q1 2024 Apr 25, 2024	BUY	$17.4 - $94.5 $1.01 Million - $5.48 Million	57,999 New	57,999 $4.76 Million
Q1 2023 Apr 27, 2023	SELL	$8.08 - $17.33 $879,532 - $1.89 Million	-108,853 Reduced 27.34%	289,240 $4.82 Million
Q4 2022 Feb 02, 2023	BUY	$2.72 - $9.4 $1.01 Million - $3.5 Million	372,508 Added 1455.96%	398,093 $3.74 Million
Q3 2022 Nov 04, 2022	BUY	$2.55 - $3.89 $65,241 - $99,525	25,585 New	25,585 $69,000
Q2 2022 Aug 03, 2022	SELL	$2.11 - $3.15 $34,040 - $50,818	-16,133 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$3.0 - $4.88 $42,801 - $69,622	-14,267 Reduced 46.93%	16,133 $48,000
Q4 2021 Feb 23, 2022	BUY	$4.6 - $6.72 $139,840 - $204,288	30,400 New	30,400 $139,000
Q2 2020 Jul 13, 2020	SELL	$4.35 - $8.08 $20,875 - $38,775	-4,799 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$3.45 - $7.95 $10,933 - $25,193	-3,169 Reduced 39.77%	4,799 $22,000
Q4 2019 Feb 05, 2020	SELL	$6.38 - $8.73 $379,246 - $518,937	-59,443 Reduced 88.18%	7,968 $63,000
Q3 2019 Oct 15, 2019	BUY	$6.55 - $8.6 $365,607 - $480,034	55,818 Added 481.48%	67,411 $463,000
Q2 2019 Jul 26, 2019	BUY	$7.67 - $10.63 $88,918 - $123,233	11,593 New	11,593 $96,000
Q1 2019 Apr 18, 2019	SELL	$7.58 - $9.94 $72,267 - $94,767	-9,534 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$7.16 - $16.21 $378,219 - $856,277	-52,824 Reduced 84.71%	9,534 $72,000
Q3 2018 Oct 23, 2018	BUY	$9.7 - $19.65 $459,818 - $931,488	47,404 Added 317.0%	62,358 $1.09 Million
Q2 2018 Jul 30, 2018	BUY	$3.88 - $12.74 $27,769 - $91,180	7,157 Added 91.79%	14,954 $141,000
Q1 2018 Apr 26, 2018	BUY	$4.11 - $6.93 $32,045 - $54,033	7,797 New	7,797 $34,000

Others Institutions Holding VKTX

# of Institutions

442

Shares Held

63.3M

Call Options Held

6.23M

Put Options Held

2.97M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.15B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Viking Therapeutics, Inc. Transaction History